Coeptis Therapeutics Inc. Quarterly Revenues in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Coeptis Therapeutics Inc. quarterly/annual Revenues history and growth rate from Q1 2020 to Q3 2022.
  • Coeptis Therapeutics Inc. Revenues for the quarter ending September 30, 2022 was $0.000.
  • Coeptis Therapeutics Inc. Revenues for the twelve months ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Revenues for 2021 was $75K, a 144% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $0 $0 -$75K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $75K $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $75K $0 -$9.89K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $84.9K $0 -$16.4K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $101K $75K +$70.5K +1564% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $30.8K $0 Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $9.89K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $16.4K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $4.51K Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.